Tumor Markers
7 markers in this category
AFP (Alpha-Fetoprotein)
An AFP (Alpha-Fetoprotein) test is part of a comprehensive health picture, measuring a protein that can be associated with various liver conditions. Elevated values have many possible explanations, including benign liver disease, and do not necessarily indicate a serious condition. This test alone cannot diagnose cancer and your healthcare professional will interpret the results alongside other clinical information.
CA 15-3
CA 15-3 is a protein associated with breast tissue that can be measured as part of a preventive health assessment. Including CA 15-3 in a routine panel helps establish a personal baseline for ongoing monitoring.
CA 19-9
CA 19-9 is a gastrointestinal marker that can be measured as part of a preventive health assessment to establish a personal baseline. Many benign conditions raise this marker, so results should always be reviewed by a healthcare professional.
CA 72-4
CA 72-4 is a gastric marker that can be measured as part of a preventive health assessment to help establish a personal baseline.
CA-125
A CA-125 test is part of a comprehensive health picture, measuring a protein that can be associated with various conditions. Elevated values have many possible explanations, including common benign gynecological conditions such as endometriosis and menstruation, as well as liver disease. This test alone cannot diagnose cancer and your healthcare professional will interpret the results alongside other clinical information to provide a complete and reassuring assessment.
CEA (Carcinoembryonic Antigen)
CEA is a broad tumor marker measurable as part of a preventive health assessment. Establishing a personal baseline and tracking trends over time is more informative than any single result.
PSA (Prostate-Specific Antigen)
PSA is a well-established marker for prostate health and an important component of preventive health assessment for men. Establishing a personal PSA baseline allows meaningful trend monitoring over time.